The Relationship between Pituitary Adenomas and the Diencephalon

  • Kalmon D. Post
Part of the Contemporary Perspectives in Neurosurgery book series (COPENEU)


Pituitary tumors are discussed in some depth throughout this volume. This chapter will focus on a few ways in which pituitary tumors interact with the hypothalamic and diencephalic regions.


Dopamine Adenoma Shrinkage Testosterone Meningitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Daughaday WH. Cushing’s disease and basophilic microadenomas. N Engl J Med 1984; 310:919–920.PubMedCrossRefGoogle Scholar
  2. 2.
    Molitch ME: ACTH-secreting adenomas, in Post KP, Jackson IMD, Reichlin S (eds): Pituitary Adenoma. New York, Plenum Press, 1980, pp 119–140.CrossRefGoogle Scholar
  3. 3.
    Schnall AM, Brodkey JS, Kaufman B, et al: Pituitary function after removal of pituitary microadenomas in Cushing’s disease. J Clin Endocrinol Metab 1978; 17: 410–417.CrossRefGoogle Scholar
  4. 4.
    Boggan JE, Tyrell JB, Wilson CB: Transsphenoidal microsurgical management of Cushing’s disease. Report of 100 cases. J Neurosurg 1983; 59: 195–200.PubMedCrossRefGoogle Scholar
  5. 5.
    Krieger DT, Amorosia L, Linich F: Cyproheptadine-induced remission of Cushing’s disease. N Engl J Med 1975; 293: 893–896.PubMedCrossRefGoogle Scholar
  6. 6.
    Findling JW, Aron DC, Tyrell JB, et al: Selective venous sampling for ACTH in Cushing’s syndrome. Ann Intern Med 1981; 94: 647–652.PubMedGoogle Scholar
  7. 7.
    Oldfield EH, Chrousos GP, Schulte HM, et al: Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sampling. N Engl J Med 1985; 312: 100–103.PubMedCrossRefGoogle Scholar
  8. 8.
    Hardy J: Cushing’s disease: 50 years later. Can J Neurol Sci 1980; 9: 375–380.Google Scholar
  9. 9.
    Lamberts SW, Uitterlinder P, Verschoor L, et al: Long-term treatment of acromegaly with somatostatin analogue SMS 201–995. N Engl J Med 1985; 313: 1576–1580.PubMedCrossRefGoogle Scholar
  10. 10.
    Lindholm J, Riishede J, Vestergaard S, et al: No effect of bromocriptine in acromegaly: a controlled trial. N Engl J Med 1981; 304: 1450–1454.PubMedCrossRefGoogle Scholar
  11. 11.
    Reichlin S, Molitch ME: Neuroendocrine aspects of pituitary adenomas. in Cammani F, Muller EE (eds): Pituitary Hyperfunction: Physiopathology and Clinical Aspects. New York, Raven Press, 1984, pp 47–70.Google Scholar
  12. 12.
    Molitch ME, Goodman RH, Post KD et al: Surgical cure of prolactinoma reverses abnormal prolactin response to carbidopa/L-dopa. J Clin Endocrinol Metab 1982; 55: 1118–1123.PubMedCrossRefGoogle Scholar
  13. 13.
    Vertosick FT: Role of defective dopaminergic inhibition of prolactin secretion in the pathogenesis of prolactinoma. Neurosurgery 1985; 16: 261–266.PubMedCrossRefGoogle Scholar
  14. 14.
    Goodman RH, Molitch ME, Post KD, et al: Prolactin secreting adenomas in the male, in Post KD, Jackson IMD, Reichlin S (eds): The Pituitary Adenoma. New York, Plenum Press, 1980, pp 91–108.CrossRefGoogle Scholar
  15. 15.
    Landolt AM: Surgical treatment of pituitary prolactinomas: postoperative prolactin and fertility in seventy patients. Fertil Steril 1981; 35: 620–625.PubMedGoogle Scholar
  16. 16.
    Serri O, Somma M, Rasio E, et al: Prolactin secreting pituitary adenomas in males: transsphenoidal microsurgical treatment. Can Med Assoc J 1980; 122: 1007–1013.PubMedGoogle Scholar
  17. 17.
    McGregor AM, Scanlon MF, Hall K, et al: Reduction in size of a pituitary tumor by bromocriptine therapy. N Engl J Med 1979; 300: 291–293.PubMedCrossRefGoogle Scholar
  18. 18.
    Thorner MO, Martin WH, Rogol AD, et al: Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab 1980; 51: 438–445.PubMedCrossRefGoogle Scholar
  19. 19.
    Landolt AM, Minder H, Osterwalder V, et al: Bromocriptine reduces the size of cells in prolactinsecreting pituitary adenomas. Experientia 1983; 39: 625.PubMedCrossRefGoogle Scholar
  20. 20.
    Tindall GT, Kovacs K, Horvath E, et al: Human prolactin-producing adenomas and bromocriptine: a histological immunocytochemical ultrastructural and morphometric study. J Clin Endocrinol Metab 1982; 55: 1178–1183.PubMedCrossRefGoogle Scholar
  21. 21.
    Weiss MH, Wycoff RR, Yadley R, et al: Bromocriptine treatment of prolactin-secreting tumors: surgical implications. Neurosurgery 1983; 12: 640–642.PubMedCrossRefGoogle Scholar
  22. 22.
    Thonier MO, Perryman RL, Rogol AD, et al: Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 1981; 53: 480–483.CrossRefGoogle Scholar
  23. 23.
    Shucart WA: Implications of very high serum prolactin levels associated with pituitary tumors. J Neurosurg 1980; 52: 226–228.PubMedCrossRefGoogle Scholar
  24. 24.
    Laws ER Jr, Kern EB: Pituitary tumors treated by transnasal microsurgery: 7 years of clinical experience with 539 patients, in Sano K, Takakura K, Fukushima T (eds): Functioning Pituitary Adenoma: Proceedings of the First Workshop on Pituitary Adenomas. Tokyo, 1980, pp. 25–34.Google Scholar
  25. 25.
    Serri O, Rasio E, Beauregard H, et al: Recurrence of hyperprolactinoma after selective transsphenoidal adenomectomy in women with prolactinomas. N Engl J Med 1983; 309: 280–283.PubMedCrossRefGoogle Scholar
  26. 26.
    Rodman EF, Molitch ME, Post KD et al: Long-term follow-up of transsphenoidal selective adenomectomy for prolactinomas. JAMA 1984; 252: 921–924.PubMedCrossRefGoogle Scholar
  27. 27.
    Vance ML, Evans WS, Thonier MO: Bromocriptine. Ann Intern Med 1984; 100: 78–91.PubMedGoogle Scholar
  28. 28.
    Krupp P, Turkalj I: Surveillance of Parlodel (bromocriptine) in pregnancy and offspring, in Jacobs HS, Harrison RF, Bonnar J, et al (eds): Prolactinomas and Pregnancy. Lancaster, England, MTP Press, 1983, pp 45–50.Google Scholar
  29. 29.
    Molitch ME, Elton RL, Blackwell RE: Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study. J Clin Endocrinol Metab 1985; 60: 698–705.PubMedCrossRefGoogle Scholar
  30. 30.
    Luzzi A, Dallabonzana D, Oppizzi G: Low doses of dopamine agonists in the long-term treatment of macroprolactinomas. N Engl J Med 1985; 313: 656–659.CrossRefGoogle Scholar
  31. 31.
    Moriondo P, Travaglini P, Nissim M, et al: Bromocriptine treatment of microprolactinomas: Evidence of stable prolactin decrease after drug withdrawal. J Clin Endocrinol Metab 1985; 60: 764–772.PubMedCrossRefGoogle Scholar
  32. 32.
    Molitch ME: Pregnancy and the hyperprolactinemic woman. N Engl J Med 1985; 312: 1364–1370.PubMedCrossRefGoogle Scholar
  33. 33.
    Gemzell C, Wang CF: Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 1979; 31: 363–372.PubMedGoogle Scholar
  34. 34.
    Konopka P, Taymond JP, Merceron RE, et al: Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 1983; 146: 935–938.PubMedGoogle Scholar
  35. 35.
    Maeda T, Ushiroyama T, Okuda K, et al: Effective bromocriptine treatment of a pituitary macroadenoma during pregnancy. Obstet Gynecol 1983; 61: 117–121.PubMedGoogle Scholar
  36. 36.
    Gen M, Uozumi T, Ohta M, et al: Necrotic changes in prolactinomas after long term administration of bromocriptine. J Clin Endocrinol Metab 1984; 59: 463–470.PubMedCrossRefGoogle Scholar
  37. 37.
    Landolt AM, Keller PJ, Froesch ER, et al: Bromocriptine: does it jeoparadize the result of later surgery for prolactinomas? Lancet 1982; 2: 657–658.PubMedCrossRefGoogle Scholar
  38. 38.
    Landolt AM, Osterwalder V: Perivascular fibrosis in prolactinomas: is it increased by bromocriptine ? J Clin Endocrinol Metal, 1984; 58: 1179–1183.CrossRefGoogle Scholar
  39. 39.
    Marcovitz S, Hardy J: Combined medical and surgical treatment of prolactin-producing pituitary tumors. Semin Reprod Endocrinol 1984; 2: 73–81.CrossRefGoogle Scholar
  40. 40.
    Weiss MH: Medical and surgical management of function in pituitary tumors. Clin Neurosurg 1981; 28: 374–383.PubMedGoogle Scholar
  41. 41.
    Weiss MH, Teal J, Gott P, et al: Natural history of microprolactinomas: six year follow-up. Neurosurgery 1983; 12: 180–183.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Kalmon D. Post
    • 1
  1. 1.Department of Neurosurgery, College of Physicians and SurgeonsColumbia UniversityNew YorkUSA

Personalised recommendations